Dr Daniel Ernest Kaminskas, MD | |
1200 N Beaver St, Flagstaff, AZ 86001-3118 | |
(928) 779-3366 | |
Not Available |
Full Name | Dr Daniel Ernest Kaminskas |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | 1200 N Beaver St, Flagstaff, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326057944 | NPI | - | NPPES |
266818 | Medicaid | AZ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 15434 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Ernest Kaminskas, MD 1200 N Beaver St, Flagstaff, AZ 86001-3118 Ph: (928) 213-6235 | Dr Daniel Ernest Kaminskas, MD 1200 N Beaver St, Flagstaff, AZ 86001-3118 Ph: (928) 779-3366 |
News Archive
Whether you're away for business or pleasure, don't let traveling be an excuse to break your healthy New Year's resolutions. Check out these tips from Jodi Sullivan, Hilton Worldwide's senior director of global fitness, to help maintain your health wherever your travels may take you.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing eleven new Collaborative Research Centers (CRC) to promote world-class research at universities. This was announced by the relevant Grants Committee, which met by video conference due to the coronavirus pandemic.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the launch of phase two of its direct-to-consumer advertising campaign.
Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
› Verified 8 days ago
Dr. Jeremy Nielsen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-779-3366 | |
Dr. Judith Amanda Kelley, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1020 N San Francisco St, Ste 100, Flagstaff, AZ 86001 Phone: 928-214-2156 | |
Kyle Richardson, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-779-3366 | |
Dr. Douglas Dean Lee, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 77 W Forest Ave, Suite 207, Flagstaff, AZ 86001 Phone: 928-773-2505 Fax: 928-773-2504 | |
Dr. James H Gibson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1020 N San Francisco St, Ste 1000, Flagstaff, AZ 86001 Phone: 928-526-1112 Fax: 928-714-9285 | |
Benjamin Schumacher, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 77 W Forest Ave Ste 117, Flagstaff, AZ 86001 Phone: 928-773-2505 Fax: 928-773-2504 | |
Dr. Gary Steven Christensen, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 77 W Forest Ave, Suite 207, Flagstaff, AZ 86001 Phone: 928-773-2505 Fax: 928-773-2504 |